162 related articles for article (PubMed ID: 37055625)
1. Candida species causing fungal keratitis: molecular identification, antifungal susceptibility, biofilm formation, and clinical aspects.
Bezerra FM; Rocchetti TT; Lima SL; Yu MCZ; da Matta DA; Höfling-Lima AL; Melo ASA; de Oliveira LA
Braz J Microbiol; 2023 Jun; 54(2):629-636. PubMed ID: 37055625
[TBL] [Abstract][Full Text] [Related]
2. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
Malchikova A; Klyasova G
J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
[TBL] [Abstract][Full Text] [Related]
5. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Candida parapsilosis complex isolates.
de Toro M; Torres MJ; Maite R; Aznar J
Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
[TBL] [Abstract][Full Text] [Related]
8. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
9. Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical
Chen YC; Chen FJ; Lee CH
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33252326
[No Abstract] [Full Text] [Related]
10.
Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
[No Abstract] [Full Text] [Related]
11. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Mohammadi F; Charkhchian M; Mirzadeh M
BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002
[TBL] [Abstract][Full Text] [Related]
12. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
Brilhante RSN; Sales JA; da Silva MLQ; de Oliveira JS; Pereira LA; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
J Med Microbiol; 2018 Jul; 67(7):903-914. PubMed ID: 29846153
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
16. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
18. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?].
Turan D; Aksaray S
Mikrobiyol Bul; 2022 Jul; 56(3):493-505. PubMed ID: 35960240
[TBL] [Abstract][Full Text] [Related]
19. Identification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India.
Kumar D; Banerjee T; Chakravarty J; Singh SK; Dwivedi A; Tilak R
Indian J Med Microbiol; 2016; 34(3):308-14. PubMed ID: 27514952
[TBL] [Abstract][Full Text] [Related]
20. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
